172 related articles for article (PubMed ID: 36273492)
21. Proteasome inhibitors and knockdown of SMG1 cause accumulation of Upf1 and Upf2 in human cells.
Zhao X; Nogawa A; Matsunaga T; Takegami T; Nakagawa H; Ishigaki Y
Int J Oncol; 2014 Jan; 44(1):222-8. PubMed ID: 24173962
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction.
Ditano JP; Donahue KL; Tafe LJ; McCleery CF; Eastman A
Sci Rep; 2021 Mar; 11(1):7077. PubMed ID: 33782497
[TBL] [Abstract][Full Text] [Related]
23. CBP80 promotes interaction of Upf1 with Upf2 during nonsense-mediated mRNA decay in mammalian cells.
Hosoda N; Kim YK; Lejeune F; Maquat LE
Nat Struct Mol Biol; 2005 Oct; 12(10):893-901. PubMed ID: 16186820
[TBL] [Abstract][Full Text] [Related]
24. UPF2, a nonsense-mediated mRNA decay factor, is required for prepubertal Sertoli cell development and male fertility by ensuring fidelity of the transcriptome.
Bao J; Tang C; Yuan S; Porse BT; Yan W
Development; 2015 Jan; 142(2):352-62. PubMed ID: 25503407
[TBL] [Abstract][Full Text] [Related]
25. Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors.
Schleicher EM; Dhoonmoon A; Jackson LM; Clements KE; Stump CL; Nicolae CM; Moldovan GL
PLoS Genet; 2020 Nov; 16(11):e1009176. PubMed ID: 33137164
[TBL] [Abstract][Full Text] [Related]
26. Targeting ATR in cancer medicine.
Sundar R; Brown J; Ingles Russo A; Yap TA
Curr Probl Cancer; 2017; 41(4):302-315. PubMed ID: 28662958
[TBL] [Abstract][Full Text] [Related]
27. A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.
Menezes DL; Holt J; Tang Y; Feng J; Barsanti P; Pan Y; Ghoddusi M; Zhang W; Thomas G; Holash J; Lees E; Taricani L
Mol Cancer Res; 2015 Jan; 13(1):120-9. PubMed ID: 25232030
[TBL] [Abstract][Full Text] [Related]
28. Arabidopsis plants having defects in nonsense-mediated mRNA decay factors UPF1, UPF2, and UPF3 show photoperiod-dependent phenotypes in development and stress responses.
Shi C; Baldwin IT; Wu J
J Integr Plant Biol; 2012 Feb; 54(2):99-114. PubMed ID: 22353561
[TBL] [Abstract][Full Text] [Related]
29. UPF2 leads to degradation of dendritically targeted mRNAs to regulate synaptic plasticity and cognitive function.
Notaras M; Allen M; Longo F; Volk N; Toth M; Li Jeon N; Klann E; Colak D
Mol Psychiatry; 2020 Dec; 25(12):3360-3379. PubMed ID: 31636381
[TBL] [Abstract][Full Text] [Related]
30. Upf1/Upf2 regulation of 3' untranslated region splice variants of AUF1 links nonsense-mediated and A+U-rich element-mediated mRNA decay.
Banihashemi L; Wilson GM; Das N; Brewer G
Mol Cell Biol; 2006 Dec; 26(23):8743-54. PubMed ID: 17000771
[TBL] [Abstract][Full Text] [Related]
31. Degradation of Gadd45 mRNA by nonsense-mediated decay is essential for viability.
Nelson JO; Moore KA; Chapin A; Hollien J; Metzstein MM
Elife; 2016 Mar; 5():. PubMed ID: 26952209
[TBL] [Abstract][Full Text] [Related]
32. Structures of SMG1-UPFs complexes: SMG1 contributes to regulate UPF2-dependent activation of UPF1 in NMD.
Melero R; Uchiyama A; Castaño R; Kataoka N; Kurosawa H; Ohno S; Yamashita A; Llorca O
Structure; 2014 Aug; 22(8):1105-1119. PubMed ID: 25002321
[TBL] [Abstract][Full Text] [Related]
33. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
Jo U; Murai Y; Chakka S; Chen L; Cheng K; Murai J; Saha LK; Miller Jenkins LM; Pommier Y
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536335
[TBL] [Abstract][Full Text] [Related]
34. Structures of nonsense-mediated mRNA decay factors UPF3B and UPF3A in complex with UPF2 reveal molecular basis for competitive binding and for neurodevelopmental disorder-causing mutation.
Bufton JC; Powers KT; Szeto JA; Toelzer C; Berger I; Schaffitzel C
Nucleic Acids Res; 2022 Jun; 50(10):5934-5947. PubMed ID: 35640974
[TBL] [Abstract][Full Text] [Related]
35. Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
Yap TA; Fontana E; Lee EK; Spigel DR; Højgaard M; Lheureux S; Mettu NB; Carneiro BA; Carter L; Plummer R; Cote GM; Meric-Bernstam F; O'Connell J; Schonhoft JD; Wainszelbaum M; Fretland AJ; Manley P; Xu Y; Ulanet D; Rimkunas V; Zinda M; Koehler M; Silverman IM; Reis-Filho JS; Rosen E
Nat Med; 2023 Jun; 29(6):1400-1411. PubMed ID: 37277454
[TBL] [Abstract][Full Text] [Related]
36. Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring
Cheruiyot A; Li S; Nonavinkere Srivatsan S; Ahmed T; Chen Y; Lemacon DS; Li Y; Yang Z; Wadugu BA; Warner WA; Pruett-Miller SM; Obeng EA; Link DC; He D; Xiao F; Wang X; Bailis JM; Walter MJ; You Z
Cancer Res; 2021 Sep; 81(17):4499-4513. PubMed ID: 34215620
[TBL] [Abstract][Full Text] [Related]
37. Nonsense-mediated mRNA decay factor Upf2 exists in both the nucleoplasm and the cytoplasm.
Tatsuno T; Nakamura Y; Ma S; Tomosugi N; Ishigaki Y
Mol Med Rep; 2016 Jul; 14(1):655-60. PubMed ID: 27221324
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon.
Cui Y; Hagan KW; Zhang S; Peltz SW
Genes Dev; 1995 Feb; 9(4):423-36. PubMed ID: 7883167
[TBL] [Abstract][Full Text] [Related]
39. Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis.
Nagar P; Islam MR; Rahman MA
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833284
[TBL] [Abstract][Full Text] [Related]
40. ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency.
Mohni KN; Kavanaugh GM; Cortez D
Cancer Res; 2014 May; 74(10):2835-45. PubMed ID: 24662920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
